The University of Illinois at Chicago has received a $5.25 million grant from the Department of Defense [DoD] to develop clinical trials using stem cells to treat eye injuries and expedite healing. The treatments utilize mesenchymal stem cells (the same type of stem cells found in teeth) due to their anti-inflammatory and immunomodulatory properties, which can help heal scarring and preserve eyesight. The treatments are targeted for combat veterans injured due to explosions and chemical burns to the eye, but could also be used to treat chronic corneal injuries in other patients.
“This is a promising line of treatment because of the extraordinary healing factors produced by these stem cells… These factors help prevent damage caused by overblown immune responses to injury, which can ultimately cause more tissue damage than the initial injury. Given that this treatment can modulate the immune response and promote true healing, we are very excited to investigate the efficacy of this treatment in humans,” comments Dr. Ali Djalilian, principal investigator of the study and Professor of Ophthalmology and Visual Sciences at UIC.
UIC’s innovative research demonstrates the integral role stem cells are playing in cutting edge medical care options. By banking their own valuable stem cells, families can ensure that they will have access to these emerging therapies in the near future. To learn more about banking stem cells, please visit StemSave or call 877-783- 6728 (877-StemSave) today.
The Future of Regenerative Medicine is Now™
To view the full article, click here.